✦ LIBER ✦

Current in vitro methods in nanoparticle risk assessment: Limitations and challenges

✍ Scribed by Alexandra Kroll; Mike H. Pillukat; Daniela Hahn; Jürgen Schnekenburger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limitations of current risk characteriza

✍ Frederik A. M. Verdonck; Tom Aldenberg; Joanna Jaworska; Peter A. Vanrolleghem 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

The contribution of in vitro toxicity da

✍ Bas J. Blaauboer 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Vulnerability assessment in natural haza

✍ Sven Fuchs, Jörn Birkmann, Thomas Glade 📂 Article 📅 2012 🏛 Springer Netherlands 🌐 English ⚖ 140 KB

Current trends and future challenges in

✍ R. C. Gogu; A. Dassargues 📂 Article 📅 2000 🏛 Springer ⚖ 268 KB

Metallic nanoparticles and in vitro cyto

✍ H. Parkkola; L. Vivero; M. Vega; M. Ramis; J. Querol; J. Sendra 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Prulifloxacin: in vitro (HERG current) a

✍ Pierre Lacroix; William J Crumb; Lucia Durando; Giovanni B Ciottoli 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 122 KB